Pseudocholinesterase deficiency: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 28: | Line 28: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
Revision as of 17:38, 18 March 2025
Pseudocholinesterase deficiency is a medical condition that is characterized by an atypical reaction to certain drugs used during general anesthesia, such as the muscle relaxants succinylcholine and mivacurium as well as certain ester local anesthetics. The condition is inherited in an autosomal recessive manner. This means the deficient individual must have two copies of the abnormal gene for the disease to develop.
Signs and Symptoms
The primary sign of pseudocholinesterase deficiency is an extended period of muscle paralysis or weakness following the administration of anesthesia. This can lead to difficulty breathing if the muscles that control breathing are affected.
Causes
Pseudocholinesterase deficiency is caused by a mutation in the BCHE gene. This gene provides instructions for making a protein called butyrylcholinesterase, which is responsible for breaking down certain drugs used during general anesthesia.
Diagnosis
The diagnosis of pseudocholinesterase deficiency usually occurs after a person has had a reaction to anesthesia. Blood tests can be done to measure the level of pseudocholinesterase in the blood.
Treatment
There is no cure for pseudocholinesterase deficiency. Management of the condition involves avoiding certain drugs that can cause a reaction. In cases where these drugs have been administered, mechanical ventilation may be required to assist with breathing until the drugs have been metabolically cleared.
See Also
References
<references />


